Loading...
Dry Eye Signs and Symptoms Persist During Systemic Neutralization of IL-1β by Canakinumab or IL-17A by Secukinumab
To evaluate whether inhibition of the proinflammatory cytokines IL-1β or IL-17A by canakinumab or secukinumab, respectively, influence the signs and symptoms of dry eye. METHODS: In a randomized, double-masked, placebo-controlled, outpatient clinical trial, 72 patients with moderate to severe dry ey...
Na minha lista:
| Udgivet i: | Cornea |
|---|---|
| Main Authors: | , , , |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
Cornea
2015
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4633966/ https://ncbi.nlm.nih.gov/pubmed/26418434 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/ICO.0000000000000627 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|